Intellia Therapeutics, Inc. (NTLA)

13.44 +0.83 (+6.58%) USD  |  NASDAQ  |  May 27, 16:00
13.30 -0.14 (-1.04%) After-Hours: 06:12
More

Intellia Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Twist Bioscience Corp. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade